The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface
- PMID: 7662169
The structure and function of the urokinase receptor, a membrane protein governing plasminogen activation on the cell surface
Abstract
Proteolytic degradation processes, resulting from the activation of plasminogen by the specific enzyme, urokinase plasminogen activator (uPA), take place in the extracellular matrix during cancer invasion as well as in tissue remodelling under certain normal-physiological conditions. The uPA receptor, uPAR, is a cell-surface protein which plays an important role in the localization and regulation of these processes. In the present article a number of established conclusions concerning the structure and function of uPAR are presented, and in addition various models are discussed which might explain additional observations for which the mechanisms involved have not yet been clarified experimentally. uPAR is a highly glycosylated, 3-domain protein, anchored in the plasma membrane by a glycolipid moiety. The domain organization is important for efficient ligand-binding, and the NH2-terminal domain is directly involved in the molecular contact with uPA. The receptor binds uPA as well as its proenzyme, pro-uPA, in such a manner that the activation cascade can occur directly on the cell surface. Furthermore, the activation rates are enhanced relative to the situation in solution, probably due to an interplay between uPAR and other, unidentified components. In addition to the function in the regulation of proteolysis, uPAR seems to play a role in internalization processes and in cellular signal transduction and adhesion. A few reagents have been identified which are capable to inhibit the interaction between uPAR and uPA. The growing knowledge on the structure and function of uPAR which is a result of protein chemical analyses, functional studies and analyses of other, interacting components, should help to obtain a better understanding of the regulation of extracellular proteolysis. In conjunction with the continuous identification of inhibitory reagents, this knowledge should open the possibility to interfere with the resulting, degradative events.
Similar articles
-
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398. Stem Cells. 1997. PMID: 9402652 Review.
-
Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.J Pept Sci. 2000 Sep;6(9):432-9. doi: 10.1002/1099-1387(200009)6:9<432::AID-PSC279>3.0.CO;2-Q. J Pept Sci. 2000. PMID: 11016879
-
The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.Biol Chem. 2004 Feb;385(2):103-36. doi: 10.1515/BC.2004.031. Biol Chem. 2004. PMID: 15101555 Review.
-
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).Biol Chem. 2001 Aug;382(8):1197-205. doi: 10.1515/BC.2001.150. Biol Chem. 2001. PMID: 11592401
-
Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.Biochemistry. 1998 Nov 24;37(47):16494-505. doi: 10.1021/bi981203r. Biochemistry. 1998. PMID: 9843416
Cited by
-
Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection.Antibiotics (Basel). 2024 Feb 12;13(2):179. doi: 10.3390/antibiotics13020179. Antibiotics (Basel). 2024. PMID: 38391565 Free PMC article.
-
The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine.J Orthop Surg Res. 2019 Nov 14;14(1):367. doi: 10.1186/s13018-019-1420-6. J Orthop Surg Res. 2019. PMID: 31727136 Free PMC article.
-
MIF promotes cell invasion by the LRP1-uPAR interaction in pancreatic cancer cells.Front Oncol. 2023 Jan 10;12:1028070. doi: 10.3389/fonc.2022.1028070. eCollection 2022. Front Oncol. 2023. PMID: 36703790 Free PMC article.
-
Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.J Cell Biol. 1998 Jan 12;140(1):233-45. doi: 10.1083/jcb.140.1.233. J Cell Biol. 1998. PMID: 9425170 Free PMC article.
-
The plasminogen system in regulating stem cell mobilization.J Biomed Biotechnol. 2012;2012:437920. doi: 10.1155/2012/437920. Epub 2012 Oct 14. J Biomed Biotechnol. 2012. PMID: 23118508 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous